MentionFox
Home › funding signals › Protogenix Inc.
Form D · on the record

Protogenix Inc. — $250K Form D filing, February 2026

Before you sell to, join or invest in Protogenix Inc.

MentionFox check on Protogenix Inc.: only 1 source on file so far (checked 5 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/protogenix-inc-form-d-26000001

Check Protogenix Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Protogenix Inc.?

Based on the record MentionFox holds for this company. No flag is not a clearance.

Protogenix Inc. filed a Form D with the Securities and Exchange Commission on 2026-02-13.

Protogenix Inc. filed a Form D notice of an exempt securities offering with the SEC on February 13, 2026. The filing reports $250K sold. Its industry group is Biotechnology. It names Christopher Wightman (Executive Officer, Director), Eric Pettee (Executive Officer, Director), Robert Poltrino (Director) (SEC Form D, February 13, 2026).

125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

5 more Biotechnology raises in New York within 90 days ↓

Is this your company?

Key facts

Run the free check on Protogenix Inc. →

Sell to companies like Protogenix Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Protogenix Inc.

New Form D on file · 2026-02-13 · the record

$250K
raise on the record
D
filing
1
investors in
NEW YORK
based
Open the record →

What the record says

FilingForm D
Filed2026-02-13
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
Year formed2021
BasedITHACA, NEW YORK
CIK2110349
Accession0002110349-26-000001

Pitching, partnering or investing alongside them? See who really runs and owns Protogenix Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Protogenix Inc., from the filings we hold.

More raises like this

Biotechnology raises by companies based in New York, filed within 90 days of this one, largest first.

What do you want to do with Protogenix Inc.?

Get the full cited report on Protogenix Inc.

What the filing shows about Protogenix Inc.

  • The filing reports $364K of the proceeds going to the company's own executives, directors or promoters.
  • 1 investor had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Protogenix Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Protogenix Inc.'s address as 237 Tower Rd, Weill Hall 409, Ithaca, NY 14853.

Keep digging

Who else raised the same week in biotechnology

What the filing says

  • Offered: $4,200,000. Sold: $250,000. Left to sell: $3,950,000. (filing)
  • Investors: 1 had already invested. (filing)
  • Date of first sale: December 24, 2025. (filing)
  • Types of securities: Equity. (filing)
  • Item 16, payments to executive officers, directors or promoters: $364,000 of the proceeds is used or proposed to be used for such payments. The filing explains: “Proceeds from this offering will be used for general corporate purposes, including working capital and product development, and may be applied toward conversion of outstanding debt owed to CEO into preferred stock in connection with this offering.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Protogenix Inc. See pricing

Is Protogenix Inc. a real, registered company?

Protogenix Inc. is a registered filer with the SEC (CIK 2110349) and has filed since 2026-02-13. 1 filing is on record, the latest on 2026-02-13.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Protogenix Inc.?

Protogenix Inc.'s Form D of 2026-02-13 names Christopher Wightman, Eric Pettee and Robert Poltrino as its officers, directors or promoters.

How much has Protogenix Inc. raised?

Its new offerings report $250K sold across 1 offering, as its own filings state.

Biotechnology · by week
This raise, $250K, filed week of Feb 9

Trailing twelve months. 765 filings in Biotechnology, totalled by week. The dot is this raise, $250K, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Protogenix Inc.?

What the filing shows about Protogenix Inc.

  • The filing reports $364K of the proceeds going to the company's own executives, directors or promoters.
  • 1 investor had already put money in when it filed.
  • The filing names 3 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Protogenix Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Protogenix Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Protogenix Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for Protogenix Inc.. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Protogenix Inc.: Raised $250K, Form D filed 2026-02-13
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/protogenix-inc-form-d-26000001
Last updated 2026-11-05
Primary record: SEC filing 1 · SEC filing 2
Protogenix Inc. raised $250K — SEC Form D filing, February 2026. MentionFox, 2026-11-05. https://mentionfox.com/funding/protogenix-inc-form-d-26000001